Will A Dividend Keep Investors Happy As Amgen Waits For Its Pipeline To Pan Out?
Amgen outlines its strategic priorities through 2016, but analysts and investors seem more concerned with near-term initiatives that could pan out before year's end.
Amgen outlines its strategic priorities through 2016, but analysts and investors seem more concerned with near-term initiatives that could pan out before year's end.